Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02098876 · ClinicalTrials.gov registry record · NA
Wall Shear Stress and Neointimal Healing Following PCI in Angulated Coronary Vessels
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 86
- Enrollment target
NCT02098876: Completed NA study, sponsored by Emory University.
NCT02098876 is a NA study that has completed, run by Emory University. The registered enrollment target is 86 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02098876, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 86 participants
- Enrollment target
Study Summary
Stents are metallic tubular supports placed inside a blood vessel to relieve an obstruction and restore blood flow to the heart muscle. Stents could also be coated with a drug (drug-eluting stents - DES) that improves local healing and inhibits growth of scar tissue within the vessel that otherwise could lead to re-narrowing. This study will evaluate the effects of 2 FDA-approved metallic stents with different designs that may have important effects on regional plaque response and blood flow dynamics immediately after stent deployment and stent healing at 12 months follow up.
Primary Outcome
Cross-sectional area in neointimal hyperplasia by Optical Coherence Tomography (OCT) at 1 year following stent placement
Interventions
- DEVICE Intravascular Ultrasound (IVUS)
- DEVICE Optical Coherence Tomography (OCT)
- DEVICE Resolute Integrity Zotarolimus eluting stent
- DEVICE Xience Xpedition everolimus eluting stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2014-05 |
| Est. Completion | 2020-12 |
| Phase | NA |
What the finished NCT02098876 record still lists
NCT02098876 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 86 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 4 interventions - of which Intravascular Ultrasound (IVUS) is the first listed.
NCT02098876 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02098876 about?
NCT02098876 is a clinical study titled "Wall Shear Stress and Neointimal Healing Following PCI in Angulated Coronary Vessels". Stents are metallic tubular supports placed inside a blood vessel to relieve an obstruction and restore blood flow to the heart muscle. Stents could also be coated with a drug (drug-eluting stents - DES) that improves local healing and inhibits growth of scar tissue within the vessel that otherwise ...
What is the current status of trial NCT02098876?
This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2014-05. Estimated completion is 2020-12.
What interventions are being tested in trial NCT02098876?
The interventions under investigation include: Intravascular Ultrasound (IVUS) (DEVICE), Optical Coherence Tomography (OCT) (DEVICE), Resolute Integrity Zotarolimus eluting stent (DEVICE), Xience Xpedition everolimus eluting stent (DEVICE).
Who is sponsoring clinical trial NCT02098876?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02098876's enrollment target sits among peer trials
86 976th of 2000 higher than 1,021 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia